Who
Myles Wolf
Director
Company insider
Files Form 4 as: Director, Akebia Therapeutics.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 6 Apr 2020
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | AKBA Akebia TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —35,700 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | AKBA Akebia Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —53,600 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | AKBA Akebia Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —53,600 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | AKBA Akebia TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —35,700 at $0.00 | filing |
| 10 Jun 2025filed 11 Jun 2025 | AKBA Akebia Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —53,600 at $0.00 | filing |
| 10 Jun 2025filed 11 Jun 2025 | AKBA Akebia TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —35,700 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | AKBA Akebia Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | AKBA Akebia TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | AKBA Akebia Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | AKBA Akebia TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 8 Jun 2022filed 9 Jun 2022 | AKBA Akebia Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —20,100 at $0.00 | filing |
| 8 Jun 2022filed 9 Jun 2022 | AKBA Akebia TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —13,700 at $0.00 | filing |
| 2 Jun 2021filed 3 Jun 2021 | AKBA Akebia TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —13,700 at $0.00 | filing |
| 2 Jun 2021filed 3 Jun 2021 | AKBA Akebia Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —20,100 at $0.00 | filing |
| 6 Apr 2020filed 7 Apr 2020 | AKBA Akebia Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —80,200 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.